Amgen Declares Impressive Dividend for First Quarter 2025 Amid Growth and Innovation
Amgen's Recent Dividend Announcement for Q1 2025
Amgen, a leader in biotechnology, has made headlines with the declaration of a $2.38 per share dividend for the first quarter of 2025. This decision comes from the company’s Board of Directors and is set to be paid on March 7, 2025, to all shareholders recorded by February 14, 2025. This generous dividend not only reflects Amgen's strong financial performance but also underscores its dedication to delivering value to its investors.
A Legacy of Innovation
Founded over four decades ago, Amgen has positioned itself at the forefront of the biotechnology industry. The company is renowned for discovering, developing, manufacturing, and delivering groundbreaking medicines. As it has progressed, Amgen has harnessed advanced technologies and leveraged human genetic data to tackle some of the world's toughest diseases, including cancer and heart disease.
In 2024, Amgen was recognized among the
Topics Financial Services & Investing）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.